Celgene (CELG) Tops Q3 EPS by 10c; Boosts FY16 EPS Outlook

October 27, 2016 7:31 AM EDT

Get access to the best calls on Wall Street with StreetInsider.com's Ratings Insider Elite. Get your Free Trial here.

Celgene (NASDAQ: CELG) reported Q3 EPS of $1.58, $0.10 better than the analyst estimate of $1.48. Revenue was $2.97 billion, versus $2.83 billion expected.

GUIDANCE:

Celgene sees FY2016 EPS of $5.88 - $5.92, versus prior guidance of $5.70 - $5.75 and the consensus of $5.77.

For earnings history and earnings-related data on Celgene (CELG) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance, Hot Earnings, Hot Guidance

Related Entities

Earnings

Add Your Comment